Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by stocksaloton Aug 19, 2010 10:44pm
341 Views
Post# 17367800

RE: Here is the release .I am a shareholder

RE: Here is the release .I am a shareholder

Sorry something got messed up in th last line.Here is the release:

Weststar Resources shareholders approve 1:12 rollback

2010-08-17 20:39 ET - News Release

Mr. Mitchell Adam reports

WESTSTAR HOLDS AGM

At Weststar Resources Corp.'s annual general and special meeting held on Aug. 16, 2010, all resolutions, as noted in the information circular, were passed, including a special resolution authorizing the consolidation of the company's common shares on a one-new-for-12-old basis, subject to TSX Venture Exchange approval. There are currently 81,609,095 common shares issued and outstanding. If the proposed consolidation of one new share for 12 old shares is approved by the exchange, there will be approximately 6,800,758 common shares issued and outstanding. The exact number of postconsolidated shares will vary depending on the treatment of fractional shares, which will occur when each shareholder's holdings in the company are consolidated. Outstanding stock options and share purchase warrants will also be adjusted by the consolidation ratio, and the respective exercise prices of such options and warrants will be adjusted accordingly. The company will not be changing its name in conjunction with the consolidation.

Bullboard Posts